Skip to main content

Animations

MJFF Publications

7611 - 7620 of 8819 Results
Title
Year
  • Year
  • 2019
  • 2019
  • 2019
  • 2019
  • 2019
  • 2018
  • 2019
  • 2019
  • 2019
  • 2019
  • Summary Details
    OPEN
    Title: Prediction of cognitive progression in Parkinson's disease using three cognitive screening measures
    Journal Name: Clinical Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.prdoa.2019.08.006
    Citation Count: 30
  • Summary Details
    OPEN
    Title: Nutritional ketosis for mild cognitive impairment in Parkinson's disease: A controlled pilot trial
    Journal Name: Clinical Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.prdoa.2019.07.006
    Citation Count: 55
  • Summary Details
    OPEN
    Title: Transportation innovation to aid Parkinson disease trial recruitment
    Journal Name: Contemporary Clinical Trials Communications
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.conctc.2019.100449
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Dopamine effects on frontal cortical blood flow and motor inhibition in Parkinson's disease
    Journal Name: Cortex
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.cortex.2019.01.016
    Citation Count: 30
  • Summary Details
    OPEN
    Title: Cysteine oxidation and redox signaling in dopaminergic neurons physiology and in Parkinson’s disease
    Journal Name: Current Opinion in Physiology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.cophys.2019.04.025
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Increased yield of full GBA sequencing in Ashkenazi Jews with Parkinson's disease
    Journal Name: European Journal of Medical Genetics
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.ejmg.2018.05.005
    Citation Count: 61
  • Summary Details
    OPEN
    Title: The second generation mixed lineage kinase-3 (MLK3) inhibitor CLFB-1134 protects against neurotoxin-induced nigral dopaminergic neuron loss
    Journal Name: Experimental Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.expneurol.2019.05.002
    Citation Count: 11
  • Summary Details
    RESTRICTED
    Title: Highly sensitive HPLC-MS/MS assay for the quantitation of ondansetron in rat plasma and rat brain tissue homogenate following administration of a very low subcutaneous dose
    Journal Name: Journal of Pharmaceutical and Biomedical Analysis
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.jpba.2019.07.014
    Citation Count: 11
  • Summary Details
    RESTRICTED
    Title: Clinical phenotype in carriers of intermediate alleles in the huntingtin gene
    Journal Name: Journal of the Neurological Sciences
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.jns.2019.05.010
    Citation Count: 31
  • Summary Details
    OPEN
    Title: Dopamine neuronal protection in the mouse Substantia nigra by GHSR is independent of electric activity
    Journal Name: Molecular Metabolism
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.molmet.2019.02.005
    Citation Count: 11
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.